PADZX | SCFQX | PADZX / SCFQX | |
Total Expense Ratio | 0.73 | 0.60 | 122% |
Annual Report Gross Expense Ratio | 0.73 | 34.13 | 2% |
Fund Existence | 14 years | 6 years | - |
Gain YTD | 0.448 | 0.391 | 114% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.41B | 1.92B | 177% |
Annual Yield % from dividends | 5.38 | 6.30 | 85% |
Returns for 1 year | 5.44 | 6.40 | 85% |
Returns for 3 years | 17.20 | 20.65 | 83% |
Returns for 5 years | 34.26 | 41.29 | 83% |
Returns for 10 years | 36.85 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBC | 18.56 | 0.24 | +1.28% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
CHI | 10.06 | 0.05 | +0.50% |
Calamos Convertible Opportunities and Income Fund | |||
USSE | 29.64 | 0.08 | +0.27% |
Segall Bryant & Hamill Select Equity ETF | |||
ARB | 28.18 | 0.01 | +0.05% |
AltShares Merger Arbitrage ETF | |||
VUSB | 49.78 | 0.02 | +0.04% |
Vanguard Ultra-Short Bond ETF |